<DOC>
	<DOCNO>NCT00299247</DOCNO>
	<brief_summary>The purpose study study resistance current malaria treatment affordable alternative uncomplicated malaria . Resistance occur area treatment use frequently . This study may help prevent future resistance . About 150 resident Buenaventura , Colombia participate . They uncomplicated malaria follow 28 day treatment . Physical exam blood draw include study visit .</brief_summary>
	<brief_title>SP Resistance Falciparum Malaria Transmission</brief_title>
	<detailed_description>Drug-resistant Plasmodium falciparum major threat global public health new strategy need deter spread resistance available forthcoming antimalarial drug . This study seek contribute understand molecular basis spread drug resistance set low level sulfadoxine-pyrimethamine ( SP ) treatment failure . The objective study compare prevalence dihydrofolate reductase ( DHFR ) dihydropteroate synthase ( DHPS ) point mutation associate SP resistance SP treatment uncomplicated Plasmodium falciparum malaria episodes measure parasite infectivity Anopheles mosquitoes post-treatment gametocyte without DHFR DHPR mutation . Patients uncomplicated falciparum malaria receive standard SP regimen closely follow 28 day . This study add new knowledge understanding way resistance spread expect provide sound basis future clinical evaluation antimalarial drug combination design prevent transmission drug-resistance malaria .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>Age 5 year Positive blood smear falciparum malaria Informed consent participant parent Intention remain study area least 4 week time enrollment Mixed Plasmodium infection Parasitemia &gt; 10 % Hematocrit &lt; 15 % Respiratory distress Spontaneous bleeding ( gum , nose , gastrointestinal tract , etc . ) Recent seizures coma Prostration weakness , patient sit walk , obvious neurological explanation Inability drink Persistent vomit History allergy adverse reaction sulfadoxinepyrimethamine ( SP ) sulfa drug Known pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Malaria , Plasmodium falciparum , drug resistance , Colombia</keyword>
</DOC>